10x Genomics, Inc. Form 8-K Summary
Business Context and Reporting Period
10x Genomics, Inc. filed a Current Report on Form 8-K on February 18, 2020, under Item 2.02 to announce financial results for the quarter and year ended December 31, 2019. The filing states that the results were issued in a press release attached as Exhibit 99.1, but the press release text is not included in the provided filing content.
Financial Metrics
- Revenue, net income or loss, cash flow, margins, debt, liquidity, and other financial metrics are not provided in the filing text.
- Non-GAAP measures, if any, cannot be determined from the provided content.
Material Changes Versus Prior Period
The filing text does not provide a clear comparison with the prior comparable quarter or year.
Guidance, Outlook, Risks, and Unusual Items
- The filing text does not provide guidance, outlook, management commentary, risk updates, contingencies, or unusual items.
- The filing is limited to furnishing the financial-results announcement and identifying the related press release as Exhibit 99.1.
- The information furnished under Item 2.02 is expressly not deemed filed for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless specifically stated.
Key Facts to Verify
- Obtain and review Exhibit 99.1 for the actual fourth-quarter and full-year 2019 financial results.
- Verify revenue growth, profitability, cash usage, cash and investments, debt, and liquidity from the attached press release or related filings.
- Review any 2020 guidance, outlook, non-GAAP reconciliations, and management commentary included in Exhibit 99.1.